These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
559 related articles for article (PubMed ID: 15714459)
1. Constitutive activation of phosphatidyl-inositide 3 kinase contributes to the survival of Hodgkin's lymphoma cells through a mechanism involving Akt kinase and mTOR. Dutton A; Reynolds GM; Dawson CW; Young LS; Murray PG J Pathol; 2005 Mar; 205(4):498-506. PubMed ID: 15714459 [TBL] [Abstract][Full Text] [Related]
2. Prolactin activates mammalian target-of-rapamycin through phosphatidylinositol 3-kinase and stimulates phosphorylation of p70S6K and 4E-binding protein-1 in lymphoma cells. Bishop JD; Nien WL; Dauphinee SM; Too CK J Endocrinol; 2006 Aug; 190(2):307-12. PubMed ID: 16899564 [TBL] [Abstract][Full Text] [Related]
3. Signal pathways involved in activation of p70S6K and phosphorylation of 4E-BP1 following exposure of multiple myeloma tumor cells to interleukin-6. Shi Y; Hsu JH; Hu L; Gera J; Lichtenstein A J Biol Chem; 2002 May; 277(18):15712-20. PubMed ID: 11872747 [TBL] [Abstract][Full Text] [Related]
4. Overexpressed eIF4E is functionally active in surgical margins of head and neck cancer patients via activation of the Akt/mammalian target of rapamycin pathway. Nathan CO; Amirghahari N; Abreo F; Rong X; Caldito G; Jones ML; Zhou H; Smith M; Kimberly D; Glass J Clin Cancer Res; 2004 Sep; 10(17):5820-7. PubMed ID: 15355912 [TBL] [Abstract][Full Text] [Related]
5. Gas6 induces Akt/mTOR-mediated mesangial hypertrophy in diabetic nephropathy. Nagai K; Matsubara T; Mima A; Sumi E; Kanamori H; Iehara N; Fukatsu A; Yanagita M; Nakano T; Ishimoto Y; Kita T; Doi T; Arai H Kidney Int; 2005 Aug; 68(2):552-61. PubMed ID: 16014032 [TBL] [Abstract][Full Text] [Related]
6. Activation of Akt and eIF4E survival pathways by rapamycin-mediated mammalian target of rapamycin inhibition. Sun SY; Rosenberg LM; Wang X; Zhou Z; Yue P; Fu H; Khuri FR Cancer Res; 2005 Aug; 65(16):7052-8. PubMed ID: 16103051 [TBL] [Abstract][Full Text] [Related]
7. Strain-induced vascular endothelial cell proliferation requires PI3K-dependent mTOR-4E-BP1 signal pathway. Li W; Sumpio BE Am J Physiol Heart Circ Physiol; 2005 Apr; 288(4):H1591-7. PubMed ID: 15591103 [TBL] [Abstract][Full Text] [Related]
8. Longitudinal inhibition of PI3K/Akt/mTOR signaling by LY294002 and rapamycin induces growth arrest of adult T-cell leukemia cells. Ikezoe T; Nishioka C; Bandobashi K; Yang Y; Kuwayama Y; Adachi Y; Takeuchi T; Koeffler HP; Taguchi H Leuk Res; 2007 May; 31(5):673-82. PubMed ID: 17007924 [TBL] [Abstract][Full Text] [Related]
9. Activation of phosphatidylinositol 3-kinase, protein kinase B, and p70 S6 kinases in lipopolysaccharide-stimulated Raw 264.7 cells: differential effects of rapamycin, Ly294002, and wortmannin on nitric oxide production. Salh B; Wagey R; Marotta A; Tao JS; Pelech S J Immunol; 1998 Dec; 161(12):6947-54. PubMed ID: 9862729 [TBL] [Abstract][Full Text] [Related]
10. Assessment of cell-signaling pathways in the regulation of mammalian target of rapamycin (mTOR) by amino acids in rat adipocytes. Pham PT; Heydrick SJ; Fox HL; Kimball SR; Jefferson LS; Lynch CJ J Cell Biochem; 2000 Sep; 79(3):427-41. PubMed ID: 10972980 [TBL] [Abstract][Full Text] [Related]
11. Activation of the Akt/mammalian target of rapamycin/4E-BP1 pathway by ErbB2 overexpression predicts tumor progression in breast cancers. Zhou X; Tan M; Stone Hawthorne V; Klos KS; Lan KH; Yang Y; Yang W; Smith TL; Shi D; Yu D Clin Cancer Res; 2004 Oct; 10(20):6779-88. PubMed ID: 15501954 [TBL] [Abstract][Full Text] [Related]
12. Determinants of rapamycin sensitivity in breast cancer cells. Noh WC; Mondesire WH; Peng J; Jian W; Zhang H; Dong J; Mills GB; Hung MC; Meric-Bernstam F Clin Cancer Res; 2004 Feb; 10(3):1013-23. PubMed ID: 14871980 [TBL] [Abstract][Full Text] [Related]
13. Activation of mammalian target of rapamycin signaling pathway contributes to tumor cell survival in anaplastic lymphoma kinase-positive anaplastic large cell lymphoma. Vega F; Medeiros LJ; Leventaki V; Atwell C; Cho-Vega JH; Tian L; Claret FX; Rassidakis GZ Cancer Res; 2006 Jul; 66(13):6589-97. PubMed ID: 16818631 [TBL] [Abstract][Full Text] [Related]
14. Activation of the p70 S6 kinase and phosphorylation of the 4E-BP1 repressor of mRNA translation by type I interferons. Lekmine F; Uddin S; Sassano A; Parmar S; Brachmann SM; Majchrzak B; Sonenberg N; Hay N; Fish EN; Platanias LC J Biol Chem; 2003 Jul; 278(30):27772-80. PubMed ID: 12759354 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of insulin signaling and adipogenesis by rapamycin: effect on phosphorylation of p70 S6 kinase vs eIF4E-BP1. El-Chaâr D; Gagnon A; Sorisky A Int J Obes Relat Metab Disord; 2004 Feb; 28(2):191-8. PubMed ID: 14970836 [TBL] [Abstract][Full Text] [Related]
16. Signal transduction pathways in androgen-dependent and -independent prostate cancer cell proliferation. Ghosh PM; Malik SN; Bedolla RG; Wang Y; Mikhailova M; Prihoda TJ; Troyer DA; Kreisberg JI Endocr Relat Cancer; 2005 Mar; 12(1):119-34. PubMed ID: 15788644 [TBL] [Abstract][Full Text] [Related]
17. ANG II activates effectors of mTOR via PI3-K signaling in human coronary smooth muscle cells. Hafizi S; Wang X; Chester AH; Yacoub MH; Proud CG Am J Physiol Heart Circ Physiol; 2004 Sep; 287(3):H1232-8. PubMed ID: 15317677 [TBL] [Abstract][Full Text] [Related]
18. Amino acid sufficiency and mTOR regulate p70 S6 kinase and eIF-4E BP1 through a common effector mechanism. Hara K; Yonezawa K; Weng QP; Kozlowski MT; Belham C; Avruch J J Biol Chem; 1998 Jun; 273(23):14484-94. PubMed ID: 9603962 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of phosphatidylinositol 3'-kinase/AKT signaling promotes apoptosis of primary effusion lymphoma cells. Uddin S; Hussain AR; Al-Hussein KA; Manogaran PS; Wickrema A; Gutierrez MI; Bhatia KG Clin Cancer Res; 2005 Apr; 11(8):3102-8. PubMed ID: 15837766 [TBL] [Abstract][Full Text] [Related]
20. G1 cell cycle progression and the expression of G1 cyclins are regulated by PI3K/AKT/mTOR/p70S6K1 signaling in human ovarian cancer cells. Gao N; Flynn DC; Zhang Z; Zhong XS; Walker V; Liu KJ; Shi X; Jiang BH Am J Physiol Cell Physiol; 2004 Aug; 287(2):C281-91. PubMed ID: 15028555 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]